Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Agenus Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
AGEN
Nasdaq
2830
www.agenusbio.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Agenus Inc.
Sanofi's Experimental Transplant Rejection Drug Gets FDA Orphan Tag
- Jun 25th, 2025 8:02 am
FDA Grants Label Expansion to AstraZeneca's Datroway in Lung Cancer
- Jun 24th, 2025 7:04 am
After Golden Cross, Agenus (AGEN)'s Technical Outlook is Bright
- Jun 19th, 2025 7:55 am
Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology
- Jun 17th, 2025 5:30 am
Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock
- Jun 16th, 2025 1:01 pm
SRPT Plummets on Second Patient Death After DMD Gene Therapy Infusion
- Jun 16th, 2025 6:45 am
Agenus Announces Virtual Annual Shareholders Meeting
- Jun 10th, 2025 11:30 am
Wall Street Analysts Believe Agenus (AGEN) Could Rally 26.6%: Here's is How to Trade
- Jun 4th, 2025 7:55 am
Agenus and Zydus sign agreements for botensilimab and balstilimab
- Jun 4th, 2025 5:33 am
Agenus to Sell US Manufacturing Facilities to Zydus Lifesciences
- Jun 3rd, 2025 9:23 am
Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US
- Jun 3rd, 2025 5:00 am
Agenus Presents New Data at ASCO Highlighting Botensilimab’s Immune Activation in MSS Colorectal Cancer
- May 30th, 2025 5:30 am
Despite Fast-paced Momentum, Agenus (AGEN) Is Still a Bargain Stock
- May 19th, 2025 6:50 am
Agenus says expanded MSS mCRC cohort data to be presented at ESMO GI
- May 16th, 2025 8:45 am
Agenus Announces New Data from Expanded MSS Metastatic Colorectal Cancer Cohort to be Presented at ESMO GI 2025
- May 15th, 2025 8:40 am
Agenus Inc (AGEN) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial Challenges
- May 13th, 2025 1:03 am
Agenus (AGEN) Reports Q1 Loss, Tops Revenue Estimates
- May 12th, 2025 6:50 am
Agenus: Q1 Earnings Snapshot
- May 12th, 2025 5:47 am
Agenus Reports Q1 2025 Financial Results and Key Business Updates
- May 12th, 2025 5:30 am
Renowned GI Oncology Leader Dr. Richard Goldberg Joins Agenus as Chief Development Officer
- May 12th, 2025 5:20 am
Scroll